In an adolescent with Prader-Willi syndrome and morbid obesity, a regimen of growth hormone therapy, aquatic rehabilitation and liraglutide was followed by weight falling from 118.6 kg to 104 kg.
In plain wordsIn one girl with Prader-Willi syndrome, weight fell further after growth hormone, water exercise and liraglutide were started together.
- Peptide
- Liraglutide
- Outcome
- DecreaseBody weight after growth hormone, rehabilitation and liraglutide
- Study
n = 1
- Outcome group
- Body weight · Metabolic and weight
Measurements
- Body weight
- 104 kg
- after regimen
- BMI
- 50.8 kg/m2
- after regimen
Source sentences
After transfer to the general ward, the patient was provided with growth hormone therapy and intensive aquatic rehabilitation and was administered liraglutide; as a result, her weight further decreased to 104 kg (body mass index [BMI], 50.8 kg/m2), and she was discharged.
1 context sentence(design, population, supporting numbers)
An 18-year-old girl with PWS presented with diffuse cellulitis and dyspnea due to severe obesity.
In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Liraglutide.